AP NEWS

DionyMed Brands Inc. to Present at The Benzinga Cannabis Capital Conference January 16th

January 8, 2019

TORONTO--(BUSINESS WIRE)--Jan 8, 2019--DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE: DYME), a multi-state cannabis brand and distribution platform, today announced that its CEO, Edward Fields, will be presenting at the Benzinga Cannabis Capital Conference, which will be held in Miami, Florida on January 15 th and 16 th, 2019 at the Eden Roc Hotel located at 4525 Collins Ave, Miami Beach, FL. Mr. Fields will give the Company presentation on January 16th at 2:50pm in Ballroom 1.

To be added to the DionyMed e-mail distribution list, please e-mail DionyMed@kcsa.com with DionyMed in the subject line.

About DionyMed Founded in 2017, DionyMed is a multi-state cannabis brands and distribution platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. DionyMed sells branded products in every category from flower to vape cartridges, concentrates and edibles. DionyMed serves more than 700 dispensaries and completes over 40,000 Direct-To-Consumer deliveries each month with its growing portfolio of products and brands. Learn more at www.DionyMed.com and follow @DYME_Inc on  Twitter  and  LinkedIn.

About Benzinga Cannabis Capital Conference Benzinga is a leading financial media outlet with extensive coverage of the cannabis space. The Benzinga Cannabis Capital Conference is recognized as the premier gathering of cannabis entrepreneurs and investors in North America. For more information on the Benzinga Cannabis Capital Conference please visit www.benzingacapitalconference.com.

Forward-Looking Information and Statements This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved” and include, without limitation, statements related to the implementation or impact of certain regulations, the expansion of the Company’s online platforms, enhancing the Company’s distribution reach and product variety and changes to the Company’s revenue drivers.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190108006063/en/

CONTACT: Edward Fields, CEO

edward@dionymed.com

408-656-4209Peter Kampian, CFO

pkampian@dionymed.com

416-209-5982Investor Contacts:

Phil Carlson / Erika Kay

KCSA Strategic Communications

Phone: (212) 896-1233

Email:pcarlson@kcsa.com/ekay@kcsa.com

KEYWORD: UNITED STATES NORTH AMERICA CANADA FLORIDA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: DionyMed Brands Inc.

Copyright Business Wire 2019.

PUB: 01/08/2019 04:23 PM/DISC: 01/08/2019 04:23 PM

http://www.businesswire.com/news/home/20190108006063/en

AP RADIO
Update hourly